Home › Funds › Commodore Capital LP › ANTX

Commodore Capital LP position in ANTX

AN2 THERAPEUTICS INC · Health Care

Commodore Capital LP reported holding 2,933,680 shares of ANTX (AN2 THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$14.2M, representing 0.85% of its reported portfolio and ranking #24 among its reported holdings. Commodore Capital LP has disclosed ANTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)2.93M sh
Reported value held$14.20M
Portfolio Weight0.85%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Commodore Capital LP's ANTX position evolved

Commodore Capital LP first disclosed a stake in ANTX in Q1 2026 at 2,333,713 shares (US$8.0M). The position peaked in Q2 2026 at 2,933,680 shares, worth US$14.2M. Across 2 filings, Commodore Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,933,680 shares valued at US$14.2M — an increase of 599,967 shares quarter over quarter.. Notable position changes include a 26% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 2.33M $7.98M New
Q2 2026 2.93M $14.20M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANTX and 13F data

ANTX (AN2 THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ANTX — the largest reported positions include Vivo Capital, LLC (US$15.3M), Spruce Street Capital LP (US$8.0M), Almitas Capital LLC (US$7.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANTX

All ANTX fund holders →

FAQ

How long has Commodore Capital LP held ANTX?

Commodore Capital LP has disclosed ANTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Commodore Capital LP's current position in ANTX?

As of Q2 2026, Commodore Capital LP holds 2.93M shares of ANTX (AN2 THERAPEUTICS INC), valued at $14.20M, representing 0.85% of its reported portfolio and ranking #24.

Has Commodore Capital LP been buying or selling ANTX?

In the latest 13F filing (Q2 2026), Commodore Capital LP increased its position in ANTX. The position peaked in Q2 2026 at 2.93M shares.

Which other funds hold ANTX?

Other major institutional holders of ANTX include Vivo Capital, LLC, Spruce Street Capital LP, Almitas Capital LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.